Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(18%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Other(2)

Detailed Status

Completed6
Recruiting2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (10.0%)
N/A9 (90.0%)

Trials by Status

completed655%
recruiting218%
unknown218%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
11